{
  "success": true,
  "sourceFile": "input/Alexion_NCT04573309_Wilsons_SAP.pdf",
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33
  ],
  "modelUsed": "gemini-2.5-pro",
  "sapData": {
    "analysisPopulations": [
      {
        "id": "pop_1",
        "name": "Screened Set",
        "populationType": "Screening",
        "instanceType": "AnalysisPopulation",
        "description": "The Screened Set will include all participants who signed an informed consent form (ICF).",
        "criteria": "Signed informed consent form"
      },
      {
        "id": "pop_2",
        "name": "Enrolled Set",
        "populationType": "Disposition",
        "instanceType": "AnalysisPopulation",
        "description": "The Enrolled Set will include all participants who were enrolled in the study.",
        "criteria": "Enrolled in the study"
      },
      {
        "id": "pop_3",
        "name": "Full Analysis Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "FA",
        "description": "The Full Analysis (FA) Set will include all enrolled participants who received at least 1 dose of ALXN1840. The FA Set will be the primary population for all efficacy analyses.",
        "criteria": "Enrolled and received at least 1 dose of ALXN1840"
      },
      {
        "id": "pop_4",
        "name": "Per Protocol Set",
        "populationType": "Efficacy",
        "instanceType": "AnalysisPopulation",
        "label": "PP",
        "description": "The Per Protocol (PP) Set will include all participants in the FA Set who have no major protocol deviations that could affect the primary efficacy endpoint. The PP Set will be used for sensitivity analyses of the primary efficacy endpoint.",
        "criteria": "Member of the FA Set with no major protocol deviations affecting the primary efficacy endpoint"
      },
      {
        "id": "pop_5",
        "name": "Safety Set",
        "populationType": "Safety",
        "instanceType": "AnalysisPopulation",
        "label": "SAF",
        "description": "The Safety Set will include all enrolled participants who received at least 1 dose of ALXN1840. The Safety Set will be the primary population for all safety analyses.",
        "criteria": "Enrolled and received at least 1 dose of ALXN1840"
      },
      {
        "id": "pop_6",
        "name": "Pharmacokinetic Analysis Set",
        "populationType": "PK",
        "instanceType": "AnalysisPopulation",
        "label": "PK",
        "description": "The Pharmacokinetic (PK) Analysis Set will include all participants in the Safety Set who have sufficient plasma concentration data to allow for the derivation of at least 1 PK parameter.",
        "criteria": "Member of the Safety Set with sufficient plasma concentration data for derivation of at least 1 PK parameter"
      },
      {
        "id": "pop_7",
        "name": "Pharmacodynamic Analysis Set",
        "populationType": "PD",
        "instanceType": "AnalysisPopulation",
        "label": "PD",
        "description": "The Pharmacodynamic (PD) Analysis Set will include all participants in the Safety Set who have sufficient PD data to allow for the derivation of at least 1 PD parameter.",
        "criteria": "Member of the Safety Set with sufficient PD data for derivation of at least 1 PD parameter"
      }
    ],
    "characteristics": [
      {
        "id": "char_1",
        "name": "Age",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Age calculated as the integer part of the number of years from the date of birth to the date of informed consent."
      },
      {
        "id": "char_2",
        "name": "Sex",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Sex of the participant."
      },
      {
        "id": "char_3",
        "name": "Race",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Race of the participant."
      },
      {
        "id": "char_4",
        "name": "Ethnicity",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Ethnicity of the participant."
      },
      {
        "id": "char_5",
        "name": "Duration of Wilson Disease",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Duration of Wilson Disease (WD) at baseline."
      },
      {
        "id": "char_6",
        "name": "Prior Wilson Disease therapy",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior therapies for Wilson Disease (WD)."
      },
      {
        "id": "char_7",
        "name": "Baseline serum copper",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Serum copper level at baseline."
      },
      {
        "id": "char_8",
        "name": "Baseline ceruloplasmin",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Ceruloplasmin level at baseline."
      },
      {
        "id": "char_9",
        "name": "Baseline 24-hour urinary copper excretion",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "24-hour urinary copper excretion at baseline."
      },
      {
        "id": "char_10",
        "name": "Medical/Surgical History",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Medical and surgical history coded using MedDRA."
      },
      {
        "id": "char_11",
        "name": "Prior and Concomitant Medications",
        "dataType": "Categorical",
        "instanceType": "Characteristic",
        "description": "Prior and concomitant medications coded using the WHO Drug Dictionary."
      },
      {
        "id": "char_12",
        "name": "Body Mass Index",
        "dataType": "Numeric",
        "instanceType": "Characteristic",
        "description": "Body mass index (BMI) calculated as weight (kg) / [height (m)]^2 at baseline."
      }
    ],
    "summary": {
      "populationCount": 7,
      "characteristicCount": 12
    }
  }
}